Splenic liposarcoma in dogs: 13 cases (2002–2012)

Krista L. A. Gower Alta Vista Animal Hospital, 2616 Bank St, Ottawa, ON K1T 1M9, Canada.

Search for other papers by Krista L. A. Gower in
Current site
Google Scholar
PubMed
Close
 DVM
,
Julius M. Liptak Alta Vista Animal Hospital, 2616 Bank St, Ottawa, ON K1T 1M9, Canada.

Search for other papers by Julius M. Liptak in
Current site
Google Scholar
PubMed
Close
 BVSc, MVetClinStud
,
William T. N. Culp Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.

Search for other papers by William T. N. Culp in
Current site
Google Scholar
PubMed
Close
 DVM
,
Lina Bravo Alta Vista Animal Hospital, 2616 Bank St, Ottawa, ON K1T 1M9, Canada.

Search for other papers by Lina Bravo in
Current site
Google Scholar
PubMed
Close
 DVM
,
Barbara Powers Flint Animal Cancer Center and Diagnostic Laboratory, Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Barbara Powers in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Stephen J. Withrow Flint Animal Cancer Center and Diagnostic Laboratory, Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.

Search for other papers by Stephen J. Withrow in
Current site
Google Scholar
PubMed
Close
 DVM

Abstract

Objective—To describe the clinical signs, diagnostic findings, surgical management, and outcome in dogs with splenic liposarcoma.

Design—Retrospective case series.

Animals—13 client-owned dogs with splenic liposarcoma.

Procedures—Medical and pathology records of dogs with a histopathologic diagnosis of splenic liposarcoma from 2002 to 2012 were reviewed for the following data: clinical signs, CBC, biochemical profile, thoracic and abdominal imaging, surgical management, histologic grade, and outcome (local recurrence, distant metastasis, and survival time). Telephone interviews were conducted with referring veterinarians.

Results—The median survival time (MST) was 623 days (range, 1 to 1,283 days). In 5 dogs that died of splenic liposarcoma, survival times ranged from 42 to 369 days. Metastasis at the time of surgery was a negative prognostic indicator: the MST was 45 days for dogs with metastasis and 767 days for dogs without metastasis. Dogs with grade 1 splenic liposarcoma had a significantly greater MST (1,009 days), compared with dogs with grade 2 or 3 splenic liposarcoma (MST, 206 and 74 days, respectively).

Conclusions and Clinical Relevance—Results confirmed that splenic liposarcoma is a rare differential diagnosis in dogs with a splenic mass. Survival time was influenced by preoperative clinical stage and histologic grade.

Abstract

Objective—To describe the clinical signs, diagnostic findings, surgical management, and outcome in dogs with splenic liposarcoma.

Design—Retrospective case series.

Animals—13 client-owned dogs with splenic liposarcoma.

Procedures—Medical and pathology records of dogs with a histopathologic diagnosis of splenic liposarcoma from 2002 to 2012 were reviewed for the following data: clinical signs, CBC, biochemical profile, thoracic and abdominal imaging, surgical management, histologic grade, and outcome (local recurrence, distant metastasis, and survival time). Telephone interviews were conducted with referring veterinarians.

Results—The median survival time (MST) was 623 days (range, 1 to 1,283 days). In 5 dogs that died of splenic liposarcoma, survival times ranged from 42 to 369 days. Metastasis at the time of surgery was a negative prognostic indicator: the MST was 45 days for dogs with metastasis and 767 days for dogs without metastasis. Dogs with grade 1 splenic liposarcoma had a significantly greater MST (1,009 days), compared with dogs with grade 2 or 3 splenic liposarcoma (MST, 206 and 74 days, respectively).

Conclusions and Clinical Relevance—Results confirmed that splenic liposarcoma is a rare differential diagnosis in dogs with a splenic mass. Survival time was influenced by preoperative clinical stage and histologic grade.

All Time Past Year Past 30 Days
Abstract Views 606 0 0
Full Text Views 3055 1954 173
PDF Downloads 1861 857 90
Advertisement